November Is National Alzheimer’s Disease Awareness Month

·        By Integral Senior Living

 In Senior Living


November Is National Alzheimer’s Disease Awareness Month

President Ronald Reagan designated November as National Alzheimer’s Disease Awareness Month in 1983. At the time, fewer than 2 million Americans had Alzheimer’s; today, the number of people with the disease has soared to nearly 5.4 million.  Get involved this month, and help raise awareness for Alzheimer’s disease.


Although Alzheimer’s affects approximately 1 in every 2 families in the U.S., and has been extensively covered in the media, there’s still quite a bit of information about Alzheimer’s that you might not be aware of.


Alzheimer’s and dementia basics 

  • Alzheimer’s is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer’s disease accounts for 60 to 80 percent of dementia cases.


  • Alzheimer’s is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer’s are 65 and older. But Alzheimer’s is not just a disease of old age. Approximately 200,000 Americans under the age of 65 have younger-onset Alzheimer’s disease (also known as early-onset Alzheimer’s).


  • Alzheimer’s worsens over time. Alzheimer’s is a progressive disease, where dementia symptoms gradually worsen over a number of years. In its early stages, memory loss is mild, but with late-stage Alzheimer’s, individuals lose the ability to carry on a conversation and respond to their environment. Alzheimer’s is the sixth leading cause of death in the United States. Those with Alzheimer’s live an average of eight years after their symptoms become noticeable to others, but survival can range from four to 20 years, depending on age and other health conditions.


  • Alzheimer’s has no current cure, but treatments for symptoms are available and research continues. Although current Alzheimer’s treatments cannot stop Alzheimer’s from progressing, they can temporarily slow the worsening of dementia symptoms and improve quality of life for those with Alzheimer’s and their caregivers. Today, there is a worldwide effort under way to find better ways to treat the disease, delay its onset, and prevent it from developing.



September is National Traumatic Brain Injury Awareness Month

National Traumatic Brain Injury Awareness Month is observed during September and sponsored by The Johnny O Foundation. National Traumatic Brain Injury Awareness Month and the Centers for Disease Control (CDC) raise awareness about traumatic brain injury (TBI). Improved prevention, recognition, and response can help address this important public health problem. Prevent traumatic brain injury by understanding the risks, signs, and symptoms.

National Traumatic Brain Injury Awareness Month educates us that the most common form of head injury is called mild traumatic brain injury, or “concussion.” Concussions don’t happen just from sports, and they don’t just happen to young adults. Concussions frequently happen to the aging population from falls and are overlooked. They are common after car accidents or any other trauma to the skull. It is also important to realize injury doesn’t necessarily correlate with how hard the blow to the head was and in 90% of cases, does not result in a loss of consciousness.

Facts and Stats on Traumatic Brain Injury:

99% of NFL players in a brain donation program were diagnosed with brain damage after death.

26,212 non-fatal bicycling related brain injuries occur annually.

2.8 million Traumatic brain injuries occurred in 2013, the most recent data from the CDC.

19.5% of high school athletes have had a concussion.

5.5% of high school athletes have had more than one concussion.

$400,000 is the lifetime cost of a severe brain injury.

153 deaths occur each day from injuries that include a brain injury.

53,000 deaths from brain injury occur each year.

47% of ER visits were for brain injuries from 2007 to 2013.

3.2 to 5.3 million Americans are living with a TBI-related disability.

70% of all sports and recreation-related brain injuries were reported in people ages 19 and younger.

National Traumatic Brain Injury Awareness Month Sponsor:
The Johnny O Foundation
To learn more, visit

The awareness color for Traumatic Brain Injury is Green.




Did you know why or how June became National Dysphagia Awareness Month?

Many Thanks to our Friends at Mass Tex Imaging and the NFOSD - National Foundation of Swallowing Disorders!

This information was obtained from the National Foundation of Swallowing Disorders

This statute was agreed to by the US House of Representatives on September 27, 2008 with the concurrence of the US Senate.

Whereas dysphagia, or difficulty with swallowing, is a medical dysfunction that affects as many as 15,000,000 Americans;

Whereas the Centers for Disease Control and Prevention has estimated that 1,000,000 people in the United States annually are diagnosed with dysphagia;

Whereas the Agency for Healthcare Research and Quality has estimated that 60,000 Americans die annually from complications associated with dysphagia;

Whereas based on Centers for Disease Control and Prevention mortality data, this is more than the total number of Americans dying from all forms of liver disease, kidney disease, and HIV/AIDS combined-and nearly as many as those dying from diabetes, the number 6 killer of Americans;

Whereas the most common complication arising from dysphagia is aspiration pneumonia-caused by food or saliva entering the windpipe and into the lungs;
Whereas one in 17 people will develop some form of dysphagia in their lifetime, including 50 to 75 percent of stroke patients and 60 to 75 percent of patients who undergo radiation therapy for head and neck cancer;

Whereas as many as half of all Americans over 60 will experience dysphagia at some point;

Whereas complications due to dysphagia increase health care costs by resultant hospital readmissions, emergency room visits, extended hospital stays, the necessity for long-term institutional care, and the need for expensive respiratory and nutritional support;

Whereas the cost of managing a patient with a feeding tube, which for many has been the primary treatment option for this condition, is reported to average over $31,000 per patient per year;

Whereas the total annual cost to Medicare just for enteral feeding supplies for outpatients was more than $670,000,000 in 2003, nearly 6 percent of the total Medicare budget for that year;

Whereas including the monies spent in hospitals, the total cost of dysphagia to the health care system is well over $1,000,000,000 annually;

Whereas the condition of dysphagia is a vastly underreported condition and not widely understood by the general public; and

Whereas observing June 2008 as National Dysphagia Awareness Month would raise public awareness about dysphagia and the need for early detection and treatment: Now, therefore, be it Resolved by the House of Representatives (the Senate concurring), that it is the sense of the Congress that a National Dysphagia Awareness Month should be established.



Thank You to the Alzheimer's Association and the Alzheimer's Impact Movement (AIM) for this important step




BOLD Infrastructure for Alzheimer’s Act

“Alzheimer’s is the most

under-recognized threat

to public health in the 21st century,”

-Dr. David Satcher, former U.S. Surgeon General and former Centers for Disease Control and Prevention (CDC) Director


Working with bipartisan Congressional champions, the Alzheimer’s Association through the Alzheimer’s Impact Movement (AIM) was instrumental in the development and introduction of the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (S. 2076/H.R. 4256). The bill would create an Alzheimer’s public health infrastructure across the country to implement effective Alzheimer's interventions focused on public health issues such as increasing early detection and diagnosis, reducing risk and preventing avoidable hospitalizations. The BOLD Infrastructure for Alzheimer's Act would also increase implementation of the Healthy Brain Initiative's Public Health Road Map nationwide by establishing Alzheimer’s centers of excellence, providing cooperative agreements to public health departments, and increasing data collection, analysis and timely reporting. Learn more about the BOLD Infrastructure for Alzheimer's Act below.

Specifically, the BOLD Infrastructure for Alzheimer's Act would direct the Centers for Disease Control and Prevention (CDC) to:

Establish Alzheimer’s Centers of Excellence:

  • The Centers will increase education of public health officials, health care professionals, and the public on Alzheimer’s, brain health, and health disparities.

  • The Centers will also provide technical assistance to public health departments across the country in implementing effective Alzheimer’s interventions.

  • These interventions will focus on priorities such as increasing early detection and diagnosis, reducing risk, preventing avoidable hospitalizations, reducing health disparities, supporting the needs of caregivers and supporting care planning for people living with the disease.

  • Finally, the Centers will expand innovative public private partnerships that focus on addressing cognitive impairment and health disparities.

    Award cooperative agreements to public health departments:

  • This funding will help public health departments implement effective Alzheimer’s interventions, including those identified by the Alzheimer’s Centers of Excellence.

  • This funding will also help public health departments implement strategic actions identified in the Healthy Brain Initiative’s Public Health Road Map.

    Increase data collection, analysis and timely reporting:

  • Cooperative agreements to public or nonprofit private entities will increase the analysis and timely public reporting of data on Alzheimer’s, caregiving, and health disparities.

  • This data will be collected using tools like the Behavioral Risk Factor Surveillance System (BRFSS), the National Health and Nutrition Examination Survey (NHANES) and the National Health Interview Survey (NHIS).

  • This funding will also help monitor the progress of the Alzheimer’s and caregiving objectives in the Healthy People 2020 report.






April is Occupational Therapy Month


During the month of April, Occupational Therapy Month recognizes all the benefits this specialized healthcare provides.

When injury strikes or long term wear of joints and muscles require rehabilitation, an occupational therapist provides the necessary exercises to get us back into our daily routines.  Simply getting out of bed may be a challenge or moving from one position to another becomes a problem we need to overcome.  Occupational therapists have studied the movements required to make these transitions happen safely and to retrain our newly repaired body part to do the job.  They know the therapies to help improve weakened muscles and alternatives when others fail us.

For every age and ability, occupational therapists provide care to improve the quality of life to each patient.



Many Thanks to Bloomberg Technology for this very informative article

FDA Opens New Path for Alzheimer's Treatments

Anna Edney, Michelle Fay Cortez and Robert Langreth

February 15, 2018 9:43 AM Updated on February 15, 2018 1:29 PM

·        Researchers haven’t settled on cause, target of disease

·        Draft guidance comes after Merck failure, years of others

U.S. drug regulators wants to let drugmakers test Alzheimer’s disease treatments on patients years before the disease shows outward signs, and could approve the therapies based on subtle biological signals rather than proof they alleviate symptoms.

The Food and Drug Administration proposal will open new paths for drugmakers after repeated failures from companies including Pfizer Inc., Eli Lilly & Co. and Merck & Co. It also poses a scientific challenge: Researchers don’t fully understand the biological progression of Alzheimer’s disease, leaving the industry without a clear finish line or target.

While the FDA acknowledges the lack of an agreed-upon target, it loosened the standard for drugmakers to move ahead. The proposal cuts a line from a 2013 policy calling for “widespread evidence-based agreement in the research community” about the right biological signal.

The new guidance “is a big deal to companies,” said Maria Carrillo, chief science officer for the Alzheimer’s Association. “It is a clear statement that the FDA understands that the science of Alzheimer’s has evolved.”

Biological Goal Post

In the proposal, the FDA said it could quickly approve a drug for people who haven’t shown outward signs of Alzheimer’s, if the therapy affects a biological marker of the disease -- similar to how lowering blood pressure reduces the risk of a heart attack. Nothing like that currently exists for the disorder, which is the sixth-leading cause of death in the U.S.

Read more: Alzheimer’s is the unbeatable enemy for drugmakers

With a drug on the market under the fast-track process, a company would then have to conduct further trials to confirm that the biological change lead to a meaningful benefit, such as slowing patients’ initial decline in mental function, known as mild cognitive impairment.

“This guideline says they are willing to entertain a cognition-only endpoint and that is big change” from the way most trials have been run in the past, said Carrillo.

There are also implications for health insurers and the government, which will face pressure to pay for new treatments for the millions of Americans who suffer from the disease, said Craig Garthwaite, a professor at Northwestern University’s Kellogg School of Management.

Alzheimer’s disease “is filled with high profile misses by pharmaceutical companies,” he said. “There could be a massive waste of resources” if drugs are approved based on biomarkers that turn out not to predict Alzheimer’s progression, he said.

Neurology Drugs

The draft guidance on Alzheimer’s disease is one of five proposals the FDA released Thursday to spur development of treatments for neurological diseases, including ALS, or amyotrophic lateral sclerosis.

“The brain, in many respects, is the last organ system where many aspects of our understanding of the underlying biology of disease remain uncertain,” FDA Commissioner Scott Gottlieb said in a statement. “Symptoms and progression of neurological diseases can also vary significantly across patients, and even within patients, and across organ systems.”

While the changes could reinvigorate research efforts for Alzheimer’s drugs, they would also ask patients and doctors to take a risk on new products that don’t have the same scientific proof behind them that comes from a trial measuring symptoms like memory and function loss.

Only Failures

There are no approved Alzheimer’s treatments that slow progression of the disease, while almost 200 drugs have failed.

Merck & Co. said this week that its trial of a drug in early stage patients was being halted, and it was considering its next steps for the compound, called verubecestat.

On Wednesday, Biogen Inc. said it was adding more patients to its study of another drug after the trial wasn’t producing a clear enough signal of the therapy’s effectiveness. Investors took it as a sign the trial -- the last remaining late-stage effort by a major drugmaker -- might fail.

Alzheimer’s is thought to build for years in the brain before outward symptoms show themselves, at which point some researchers believe it may be too late. By focusing on patients with the earliest biological stages of the disease, it may be possible to intervene before serious damage is done.

Those people -- with no symptoms, no medical complaints and no detectable abnormalities -- will be categorized as stage 1 patients.

Patients with stage 2 disease have subtle abnormalities, but haven’t begun to lose ability to perform basic functions. Stage 3 patients have signs of disease, including mild functional impairment. It’s not until stage 4 that patients are classified with mild dementia.




Many Thanks to Partners In Parkinson's for this valuable Webinar resource

Care Beyond the Clinic: How to Gain Control of Your Parkinson’s by Optimizing your Personal Health Strategies


DATE: Wednesday, October 4, 2017
TIME: 12-1pm EST
TITLE: Care Beyond the Clinic: How to Gain Control of Your Parkinson’s by Optimizing your Personal Health Strategies

Register Now

If you have previously registered for this event, please login below:



Zip Code*



First Name*

Middle Initial

Last Name*


Gender Please chooseMaleFemale

Date of birth

Zip Code*

What is your primary connection to Parkinson's disease?* Please choose from the dropdownI have PDI work in the PD communityFamily Member has PDFamily Member had PDFriend has PDFriend had PDOther

How did you find out about this webinar? Please choose from the dropdownThe Michael J Fox Foundation (email, website, mailing)Fox Foundation Social media (Facebook, Twitter, Pinterest)Fox Trial FinderPartners in Parkinson's emailAbbVie Parkinson's disease AdvocateFriend or family memberDoctor or medical care providerSupport groupLocal or national Parkinson's organizationRadioOnline adNews (newspaper or TV)PostcardOther

Do you have a question you would like to submit in advance?

I would like to receive periodic emails from The Michael J. Fox Foundation for Parkinson's Research with research news updates, information about clinical studies and opportunities to participate in the PD community.* Please choose from the dropdownYes! Sign me upNo, thanks

I would like to receive periodic emails from AbbVie and its contracted third parties with information about advancing Parkinson's disease as well as AbbVie treatments, products, and services. AbbVie will not sell or transfer my name or contact information to any third party for their marketing use.* Please choose from the dropdownYes! Sign me upNo, thanks

*Denotes required.


By clicking "Register", you agree to enroll into the Partners in Parkinson's program, which includes email communications about Partners in Parkinson's events in your area as well as updates on access to new tools and resources as they become available. You also attest that you are at least 18 years of age or older. To opt-out of the Partners in Parkinson's program, please contact us at The Privacy Policy is available at

Partners in Parkinson's offer webinars in addition to community events. Visit for more information.

You must have Javascript and Cookies enabled to access this webcast. Click here for Help



June is National Dysphagia Awareness Month

Many Thanks to our friends at the NFOSD (National Foundation of Swallowing Disorders) and Tiffany Turner MS, CCC-SLP for this great article on Dysphagia.


Deciphering Dysphagia

Published 9.28.2016 by NFOSDadmin


Byline: Tiffany Turner, MS, CCC-SLP, Owner, Swallowing and Neurological Rehabilitation, Tiffany founded a dysphagia focused outpatient center in 2014 to serve the northeastern Oklahoma region and fill a gap in her community, as she feels adult speech pathology services are often misunderstood and underutilized. She is also an author and publishes resources for other SLPs to use with their patients which have been downloaded by over 2,000 speech-language pathologists worldwide.

Dysphagia, or difficulty swallowing, affects up to 15 million adults in the United States. According to past publications, 1 in 25 people will experience some form of dysphagia in their lifetime, including 22% of those age 50 and older (ASHA, 2008; Bhattacharyya, 2014). People at the greatest risk for swallowing impairments include individuals who have had strokes, those with neurological conditions (such Parkinson’s disease), survivors of head and neck cancer, and the elderly. Despite the significant prevalence of dysphagia, this medical condition is often neglected, and many sufferers are never properly diagnosed or treated.


How Swallowing Works

There are three phases of swallowing. The first phase of swallowing is the oral phase, where food or liquid is manipulated and prepared to be swallowed (by chewing, forming the food into a cohesive unit in the mouth (a.k.a. a bolus). Next, in the pharyngeal phase, after the food or liquid passes through the mouth, it approaches two ‘tubes’ at the back of the throat- the esophagus (a passageway to the stomach) and the trachea (airway). There are several muscles that go to work to ensure the food then goes from the back of the throat down the esophagus rather than into the trachea (which leads to the lungs). When the muscles involved in swallowing are working properly, they close off and protect the airway to prevent food or liquid from entering the lungs. Lastly, the food/liquid then passes from the top to the bottom of the esophagus in the esophageal phase of swallowing. From the bottom of the esophagus, the food/liquid enters into the stomach.

Speech-language pathologists are the specialists who evaluate and treat impairments of the oral and pharyngeal phases of swallowing since the same general anatomy is involved for both swallowing and speech/voice. Esophageal phase dysphagia is often treated by an otolaryngologist or gastroenterologist depending on the specific impairment.


Symptoms and Complications

Dysphagia can be the result of muscle damage, nerve damage, or other causes and can occur at any phase of the swallow, so there are many different presentations of this condition depending on the underlying cause and specific areas affected. Some symptoms of oral or pharyngeal dysphagia could include the following:

  • difficulty moving food from the front to the back of the mouth,

  • difficulty chewing,

  • food getting stuck in the mouth,

  • difficulty swallowing certain foods/drinks,

  • coughing or throat clearing while eating/drinking,

  • feeling like foods/pills are getting stuck, and/or

  • a wet vocal quality (e.g., a gurgling sound) after eating/drinking.


    When the pharyngeal swallowing mechanism isn’t functioning like it should, food or liquid can sometimes enter the trachea instead of the esophagus. This is referred to as aspiration. Everyone experiences occasional aspiration of trace amounts (that feeling when something goes down the wrong way and your body’s reaction is to cough). However, when aspiration is persistent and foreign material is entering the lungs, this can lead to very serious complications, such as aspiration pneumonia or even death.

    Swallowing experts have developed a short, 10-question, self-assessment survey developed to help patients communicate the signs and symptoms of their swallowing problem with their healthcare team called the Eating Assessment Tool (EAT-10). This assessment tool is not a replacement for tools already in use by the medical team, but can be used as a tool to help patients identify a swallowing problem. Problem identification is an early step in the path to a treatment plan and can result in improved outcomes. The following link will open up the survey. The survey can be taken online and printed out or it can be printed out and filled in on paper.


    Treatment Options

    We know there are many things that can go wrong with swallowing and the consequences can be very serious, so what options are available for those living with dysphagia? Below are some of the most effective and widely used treatment techniques that speech-language pathologists can implement to help manage oral and pharyngeal dysphagia.

1.      One common method of treatment involves exercises to strengthen and improve the functioning of the specific muscles that are negatively affecting the swallow.  First, the speech-language pathologist will complete an instrumental assessment to determine the specific impairments; then, exercises will be prescribed to target those specific areas of deficit. Some patients are candidates for neuromuscular electrical stimulation and/or biofeedback training along with traditional exercises to promote more intensive treatment and in some cases more rapid muscle re-education.

  1.   Another common approach involves education of compensatory strategies to decrease the risk of aspiration. For example, for some patients, tucking the chin downward while swallowing can help close off the airway and prevent aspiration.  For other patients with more weakness on one side or the other, a head turn to one side may increase swallowing safety. A speech-language pathologist can teach specific and individualized postures and techniques to increase safety depending on specific impairments noted during instrumental assessment.

  1.   A third option in dysphagia management involves diet texture modification. Certain food or liquid textures can be substituted to decrease aspiration risk. For example, thickened liquids flow more slowly than regular liquids and give the muscles more time to react and protect the airway, reducing the aspiration risk for some people. Some patients may need smoother textured foods if mastication or oral or pharyngeal residue poses safety risks. Diet consistency recommendations are very individualized based on the assessment findings. A last resort may involve a feeding tube and nothing by mouth (either temporarily or in some cases long-term) to prevent food/liquid from entering the airway if all oral intake appears unsafe.

    If you feel that you or a loved one may be suffering from dysphagia, discuss your symptoms with your physician and seek a speech-language pathology consultation. Without treatment, dysphagia can be a debilitating condition, but thankfully quality of life can be improved greatly with proper and timely diagnosis and treatment. Early intervention results in the best treatment outcomes, so seeking treatment at the first sign of an impairment is very important.


    Additional NFOSD Dysphagia Resources

    Head & Neck Cancer

    How Aging Affects the Swallow

    Parkinson’s Disease

    Pediatric Swallowing Disorders

    Stroke & Dysphagia


    Statistical References

    ASHA Communication Facts: Special Populations: Dysphagia- 2008 Edition. American Speech-Language-Hearing Association, 2008.

    Bhattacharyya, N. (2014). The prevalence of dysphagia among adults in the United States. Otolaryngology–Head and Neck Surgery, 151, 765–769.





NFOSD Online swallowing support group

Many Thanks to the National Foundation of Swallowing Disorders for providing this valuable resource!




The National Foundation of Swallowing Disorders
is excited to announce its

Online Swallowing Support Group

Join the Support Group:

It is estimated that 560 million people worldwide suffer from a swallowing disorder. While the National Foundation of Swallowing Disorders has helped to establish several local swallowing support groups, we recognize that this is not enough. 

Therefore, we have created an online, interactive support group using Facebook. This group is open to all those impacted by swallowing disorders including patients, family members, caregivers, and friends as a way to easily share your stories, resources, questions, answers, and support with others.

Clinicians are welcome to join this group, however, because this is an NFOSD-sponsored group, we kindly ask that they do not share medical advice. We understand that each individual is different -- the cause of a swallowing disorder, the signs and symptoms, and the effect of the disorder on the individual can vary greatly. We welcome the expertise, resources, and support that clinicians may be able to offer to others in this group. 

If you have questions about how to join the group, please email us at

The NFOSD Team



Archive for the ‘Veterans Benefits’ Category

Will VA Benefits Pay for Senior Care?

Monday, May 30th, 2016 by SeniorHomes Staff Writers


If you’re a U.S. military veteran who is planning for your own long-term senior care or the care of an aging loved one who is a veteran, you’ve probably considered whether VA benefits could help cover the costs of that care. If this is the case, you’re in good company. According to a 2012 census figures, more than 12.4 million veterans over the age of 65 live in the U.S.. With the average annual senior care costs ranging from $17,680 to $92,378 for care ranging from adult day health care to private nursing homes each year, financial help is essential.

What Are Aid and Attendance Benefits?

The costs of long-term care add up quickly. VA benefits like the Aid and Attendance Benefit can help significantly, even if the veteran’s income is above the limit for a pension. For eligible veterans and their spouses, the Aid and Attendance Benefit can help cover the costs of a variety of types of senior care, including assisted living, in-home care, and nursing home care.

The VA pays Aid and Attendance Benefits to a veteran in addition to monthly pension benefits. These benefits are also paid to survivors of veterans who have been collecting death pensions. Aid and Attendance Benefits may add $700 each month for veterans and $500 per month for survivors. This type of benefit is available for veterans who have served 90 days or more, one of those days being during a time of war.

Who is Eligible for Aid and Attendance Benefits?

These benefits are set aside for individuals who require assistance to perform daily activities, including bathing, feeding, dressing, and getting out of bed. It is also available for patients in nursing homes, those who are blind, and those who are undergoing treatment for a disability. Eligibility depends on whether the veteran is receiving a VA pension or if the veteran’s survivors are receiving a death pension. Either party must provide a primary doctor’s report as evidence of a qualifying condition.

How to Apply for VA Benefits

Applying for veterans’ benefits starts by contacting the regional office for the VA where the veteran previously applied for a pension or the survivor filed for a death pension. The VA will place the veteran into a priority group and make contact when the claim has been filed.

Unfortunately, all too many veterans and their loved ones don’t know that there are benefits available to help pay for the costs of senior care. With these rates rising every year, VA benefits can make a significant difference in the type of care that aging veterans can afford.



Despite failed trials, experts believe we'll have an Alzheimer's drug by 2025

By Meera Senthilingam, CNN

Updated 3:02 PM ET, Fri December 9, 2016

(CNN) The results of recent trials that tested much-anticipated Alzheimer's disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last month.

But experts across the field say hope is not lost. They believe we will have some form of drug against the disease by 2025, albeit most likely a pilot version that will need to be upgraded.

This target, in less than a decade, is the goal set by world leaders at the G8 dementia summit in 2013.

Researchers believe there are enough competitors in the race to get at least a few to the finish line on time.

"There are still a number of late-stage trials in progress," said Heather Snyder, senior director of medical and scientific operations at the Alzheimer's Association. "2025 is a realistic target in terms of where we are with the science. ... We're not off-track at this point in time."

Read More

Twenty-four drug candidates are currently in phase 3 trials on humans -- trials that involve larger numbers of people and a comparator to see a drug's true effect -- and many more potential drugs are in earlier stages of development. Speaking from the Clinical Trials on Alzheimer's Disease conference in San Diego this week, Snyder is hopeful that a few drug options -- not just one -- may surface to one day treat Alzheimer's at various stages of the disease.

The question now is, which trials will they be? Unlike with many other diseases, scientists don't fully understand the underlying causes of Alzheimer's, meaning drugs now in development are targeting different aspects of what is theorized to cause symptoms.

"This is a complex disease," Snyder said. "If you think of HIV or cancer ... we don't treat those diseases with one drug." The end result may have to be a combination therapy.

It's estimated that 46.8 million people were living with dementia worldwide in 2015, of which Alzheimer's disease is considered to be the leading cause. More than 5 million people are living with the condition in the United States.




The Edgewood Centre, Portsmouth, NH


An In-Service and Tasting of Gourmet Pureed was held at The Edgewood Centre in Portsmouth, New Hampshire recently.  All agreed that Gourmet Pureed was an excellent, tasty and nutritious option for their clients going home on a pureed diet. 

In attendance were individuals from Speech Language Pathology, Occupational, Physical and Restorative Therapy, Dietary, Social Work, the Director of Rehabilitation and the President and Owner of The Edgewood Centre.

Located in the historic seaside town of Portsmouth, New Hampshire, The Edgewood Centre is a family owned facility which specializes in providing Short Term Stay, Skilled Nursing, Dementia Care and Long Term care in a warm, welcoming environment.

Thank You for your invitation to conduct our In-Service and your kind words for Gourmet Pureed!